Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Behaviour of smokers and their influencers in the UK during COVID-19 pandemic

Sudhanshu Patwardhan, Claudia Trainer
doi: https://doi.org/10.1101/2021.05.25.21257716
Sudhanshu Patwardhan
1Centre for Health Research and Education, University of Southampton Science Park, Chilworth, United Kingdom
Roles: Director
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sud@chre-uk.com
Claudia Trainer
2Behavioural Science Practice, Ogilvy Consulting, Sea Containers House, London, United Kingdom
Roles: Consultant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose The COVID-19 pandemic has resulted in unprecedented circumstances and changes in behaviour. This research sought to better understand the impact of the COVID-19 pandemic, and lockdown, on smoking behaviour in the UK from the perspectives of consumers (current and former smokers) and some of their smoking-related behaviour-influencers.

Design/methodology/approach This research project encompassed two surveys, one for current and former smokers (Consumers) and one for those individuals in professions with the potential to influence smoking behaviours (Influencers). Both surveys were conducted online and were infield for approximately two weeks during UK’s first COVID-19 lockdown. Because of the unprecedented times the society was experiencing, several questions relating directly to COVID-19 were added to the survey and this paper is based only on findings only from those questions and not the whole project. The results were analysed descriptively.

Findings A total of 954 consumers and 1027 influencers participated in the surveys. Increased smoking was reported by 67% of the consumers mainly due to stress and boredom arising out of COVID-19 lockdown. Consumers under 45 years of age, those in professional and managerial occupations, and among dual users reported increased smoking in lockdown. The COVID-19 situation changed the plans to quit smoking in 36% of consumers, with only 6% deciding to quit. Only 40% of healthcare professionals (HCPs) documented patient smoking status in over half their interactions.

Originality/ value This research among current and former smokers and their influencers highlights important changes in behaviour during the COVID-19 times and underscores urgent measures to be taken by HCPs and policymakers for staying on course of achieving smokefree goals despite challenges posed by COVID-19.

Competing Interest Statement

Dr Sudhanshu Patwardhan (SP) is a paid Director at Centre for Health Research and Education (CHRE), an independent healthcare company which works on global smoking cessation and cancer prevention projects. CHRE has received grants from Foundation for a Smoke-free World, Inc for some of its smoking cessation projects, including towards this project. Previously, SP was an employee of Nicoventures, a wholly owned subsidiary of British American Tobacco, till February 2019. Ms Claudia Trainer (CT) is a paid employee at Ogilvy Consultings Behavioural Science Practice. CTs employer (Ogilvy UK, part of WPP plc) has provided consulting-type support on paid projects to tobacco companies, such as PMI, in the last 36 months. These projects aimed to identify ways of encouraging smokers to switch from cigarettes to reduced harm products. CT has not worked on these projects and has no direct relationships, personally or paid, with these companies.

Clinical Trial

This was not a clinical trial or a prospective study. It was a cross sectional survey without any intervention or clinical measurements. The individuals were assessed in this survey using a questionnaire.

Funding Statement

This paper is part of Centre for Health Research and Education (CHRE)s Smokefree UK project. CHRE is an independent healthcare company which works on global smoking cessation and cancer prevention projects. The project is conceptualised, designed, led and managed by CHRE. CHRE applied for and was awarded a grant from the Foundation for a Smoke-Free World, Inc (FSFW) for a part of the Smokefree UK project. The contents, selection, and presentation of facts, as well as any opinions expressed herein are the sole responsibility of the authors and under no circumstances shall be regarded as reflecting the positions of FSFW.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

It was confirmed with the UK Health Research Authority that HRA and HCRW Approval was not required for this study (Communication dated 1st May 2020).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data related to this project is available on the website: www.smoke-free.uk

http://www.smoke-free.uk

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 26, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Behaviour of smokers and their influencers in the UK during COVID-19 pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Behaviour of smokers and their influencers in the UK during COVID-19 pandemic
Sudhanshu Patwardhan, Claudia Trainer
medRxiv 2021.05.25.21257716; doi: https://doi.org/10.1101/2021.05.25.21257716
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Behaviour of smokers and their influencers in the UK during COVID-19 pandemic
Sudhanshu Patwardhan, Claudia Trainer
medRxiv 2021.05.25.21257716; doi: https://doi.org/10.1101/2021.05.25.21257716

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9785)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2319)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11657)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2149)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4674)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)